SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-041606
Filing Date
2021-06-17
Accepted
2021-06-17 17:50:17
Documents
1
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6406
  Complete submission text file 0001209191-21-041606.txt   8518
Mailing Address BAYERWERK, GEBAEUDE W11 KAISER-WILHELM-ALLEE LEVERKUSEN 2M D-51368
Business Address BAYERWERK, GEBAEUDE W11 KAISER-WILHELM-ALLEE LEVERKUSEN 2M D-51368 492143081933
BAYER AKTIENGESELLSCHAFT (Reporting) CIK: 0001144145 (see all company filings)

Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40498 | Film No.: 211026132
SIC: 2834 Pharmaceutical Preparations

Mailing Address ENERGIEWEG 1 MIJDRECHT P7 3641
Business Address ENERGIEWEG 1 MIJDRECHT P7 3641 00 31 297 280 666
Bayer World Investments B.V. (Reporting) CIK: 0001820027 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40498 | Film No.: 211026131

Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Issuer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)